abstract |
The present invention relates to novel methods and combinations for the treatment and / or prevention of pathological diseases in a subject, the method comprising administering at least one HMG Co-A reductase inhibitor and at least one aldosterone receptor antagonist. Wherein the combination comprises at least one HMG Co-A reductase inhibitor and at least one of the aldosterone receptor antagonists. |